These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 33239504)
1. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma. Kwon R; Argani P; Epstein JI; Lombardo KA; Wang X; Pierorazio PM; Mehra R; Matoso A Am J Surg Pathol; 2021 Apr; 45(4):450-462. PubMed ID: 33239504 [TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients. Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma]. Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864 [No Abstract] [Full Text] [Related]
4. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300 [TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma in tuberous sclerosis complex. Yang P; Cornejo KM; Sadow PM; Cheng L; Wang M; Xiao Y; Jiang Z; Oliva E; Jozwiak S; Nussbaum RL; Feldman AS; Paul E; Thiele EA; Yu JJ; Henske EP; Kwiatkowski DJ; Young RH; Wu CL Am J Surg Pathol; 2014 Jul; 38(7):895-909. PubMed ID: 24832166 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma]. Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221 [TBL] [Abstract][Full Text] [Related]
7. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture. Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172 [TBL] [Abstract][Full Text] [Related]
8. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients. Lau HD; Chan E; Fan AC; Kunder CA; Williamson SR; Zhou M; Idrees MT; Maclean FM; Gill AJ; Kao CS Am J Surg Pathol; 2020 Jan; 44(1):98-110. PubMed ID: 31524643 [TBL] [Abstract][Full Text] [Related]
9. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965 [TBL] [Abstract][Full Text] [Related]
10. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases. He H; Trpkov K; Martinek P; Isikci OT; Maggi-Galuzzi C; Alaghehbandan R; Gill AJ; Tretiakova M; Lopez JI; Williamson SR; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Pivovarcikova K; Michalova K; Slouka D; Prochazkova K; Hora M; Bonert M; Michal M; Hes O Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607 [TBL] [Abstract][Full Text] [Related]
11. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164 [TBL] [Abstract][Full Text] [Related]
12. VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney. Wang L; Zhang Y; Chen YB; Skala SL; Al-Ahmadie HA; Wang X; Cao X; Veeneman BA; Chen J; Cieślik M; Qiao Y; Su F; Vats P; Siddiqui J; Xiao H; Sadimin ET; Epstein JI; Zhou M; Sangoi AR; Trpkov K; Osunkoya AO; Giannico GA; McKenney JK; Argani P; Tickoo SK; Reuter VE; Chinnaiyan AM; Dhanasekaran SM; Mehra R Am J Surg Pathol; 2018 Dec; 42(12):1571-1584. PubMed ID: 30285995 [TBL] [Abstract][Full Text] [Related]
13. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Gupta S; Swanson AA; Chen YB; Lopez T; Milosevic D; Kipp BR; Leibovich BC; Thompson RH; Herrera-Hernandez L; Cheville JC; Jimenez RE Hum Pathol; 2019 Sep; 91():114-122. PubMed ID: 31299266 [TBL] [Abstract][Full Text] [Related]
14. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma. Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614 [TBL] [Abstract][Full Text] [Related]
15. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm. Chen YB; Mirsadraei L; Jayakumaran G; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE Am J Surg Pathol; 2019 Jan; 43(1):121-131. PubMed ID: 30303819 [TBL] [Abstract][Full Text] [Related]
16. Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors. Hamza A; Sirohi D; Smith SC; Amin MB Adv Anat Pathol; 2021 Nov; 28(6):396-407. PubMed ID: 34561376 [TBL] [Abstract][Full Text] [Related]
17. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422 [TBL] [Abstract][Full Text] [Related]
19. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution. Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401 [TBL] [Abstract][Full Text] [Related]
20. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]